Thu, Apr 27, 2017
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing Weekly

Hedge fund managers feel “pressured to violate law”: hedge fund news, Week 14

Saturday, April 06, 2013

One in three hedge fund employees admitted to having “personally observed” rule-breaking at work, a survey conducted by U.S. law firm Labaton Sucharow revealed, raising serious concerns about fraud in the industry, said The Telegraph, and 35% reported “feeling pressured by their compensation or bonus plan to violate the law or engage in unethical conduct”.

In the week ending 5 April 2013, Natixis Global A.M. launched the Aurora Horizons Fund, a multi-strategy mutual fund dynamically allocated across multiple hedge fund managers; Agcapita Partners launched the Agcapita Farmland Fund IV; Lyxor A.M. and alternative asset manager Canyon partnered to launch a UCITS-compliant credit strategy fund; Sprott A.M. started its first global macro multimanager fund; Maverick Capital's Michael Pausic said he would be starting his own hedge fund; Deer Park Road, a distressed real estate and asset-backed fixed-income manager, said it would launch its latest fund, the Burgess Creek Fund in June; and Snehal Amin, the number two at Theleme Partners has reportedly left to set up his own investment firm.

Henri Capital Partners, a London-based hedge fund firm founded by two former Winton Capital analysts, closed down as it failed to raise money.

The Opalesque A SQUARE Index declined 0.52% in February (+0.48% YTD); The Credit Suisse LAB Index was up 1.22% in March (+2.17% YTD); The HFRX Global Hedge Fund Index returned 0.72% (+3.13% YTD): The HFRU Hedge Fund Composite Index posted a gain ......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Alternative asset firm YieldStreet surpasses $100m of loans funded in less than 8 quarters[more]

    Komfie Manalo, Opalesque Asia: Alternative asset investment platform YieldStreet reported that it has surpassed $100m in loans funded in less than eight quarters from accredited investors and single family offices. YieldStreet was founded by Milind Mehere and Michael Weisz. In a

  2. Investing - Investor appetite for high-growth IPOs to be tested, Apollo boosts fund's stock allowance for 'diamonds in the rough', Hedge funds uncertain over outlook for Hargreaves Lansdown[more]

    Investor appetite for high-growth IPOs to be tested From FT.com: The US listings market is poised for a busy week with deals that will test investors' appetite for high-growth - but lossmaking - companies. Eight new listings are scheduled for this week, the most since October of 2016,

  3. Hedge funds holding Puerto Rico bonds are looking at a long battle[more]

    Komfie Manalo, Opalesque Asia: Hedge funds which bought Puerto Rico's distressed debt bonds are facing the prospect of a long road ahead to recover their investments as the Caribbean island is attempting to use a U.S. Congress-approved rule that allows it to exploit a bankruptcy-like proceedings

  4. Other Voices: "Winner-take-all" dynamics and hedge fund investing[more]

    A growing stream of thinking in microeconomics is the concept of "winner-take-all" dynamics. The idea seems simple. A combination of networking economics and classic economies of scale creates situations where there are just a few dominant firms or economic agents who are able to capture significant

  5. Investing - How Chipotle's comeback attracted big data robots and value investors alike[more]

    From Forbes.com: When William Ackman's ailing hedge fund Pershing Square Capital Management bet $1 billion on shares in Chipotle Mexican Grill beginning in July 2016, the stakes couldn't have been higher. Pershing Square was reeling from what would eventually be a near $4 billion loss in drugmaker V